Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Sysmex Corporation
- Novo Nordisk
Rentabilidad comparada (base 100)
Cada activo vale 100 el 13 de octubre de 2025; un valor de 120 significa +20 % desde esa fecha (última fecha común: 9 de octubre de 2026).
Each performance is calculated in the asset's trading currency, without currency conversion.
Indicadores
«N/A» indica un indicador que no tiene sentido para este tipo de activo: no debe compararse.
| Indicador | Sysmex CorporationStock | Novo NordiskStock |
|---|---|---|
| Rentabilidad y riesgo | ||
| Performance over the periodChange in price between the first and last common dates. | −3.8% | −31.7% |
| Annualized performanceAverage annual return that would produce the same total performance. | −3.9% | −32.0% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 40.1% | 47.8% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −33.3% | −43.1% |
| Sharpe RatioReturn achieved above the risk-free rate (5.24%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | -0.03 | -0.63 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −3.9% | −4.2% |
| Fundamentales | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 7.11B $ | 1.13T DKK |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 28.7 | 9.8 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 0.0 | 3.4 |
| Net marginShare of revenue retained as profit. | 7.5% | 35.3% |
| Return on equityReturn on equity (ROE). | 8.3% | 59.8% |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +23.6% | +2.1% |
| Dividend yieldAnnual dividend relative to the share price. | 2.02% | 4.68% |
| Debt / equityFinancial debt relative to shareholders' equity. | 25% | 63% |
Correlaciones en el periodo
De −1 a 1: cerca de 1, los dos activos suben y bajan juntos; cerca de 0, evolucionan de forma independiente.
- Sysmex Corporation / Novo Nordisk0,08
Análisis comparativo
Análisis generado por IALa IA compara los activos seleccionados solo a partir de las cifras anteriores, señalando lo que no es comparable. El texto solo se genera a petición suya.
Información facilitada con fines pedagógicos. No constituye asesoramiento en inversiones ni una recomendación personalizada. Las rentabilidades pasadas no garantizan las rentabilidades futuras.